Quick Dive: Digital solutions to optimize heart failure therapy

 

In our "Quick Dive" series, the authors of publications from medical societies concisely present the most important background and content of the respective publication. This time we dive into:

 

Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure

A clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum

30 August 2024 | Written by: Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Lis Neubeck, Alexander R Lyon, Nurgul Keser, Marcin Rucinski, Maria Marketou, Ekaterini Lambrinou, Maurizio Volterrani, Loreena Hill.


By:

Martin Nölke

HERZMEDIZIN editorial team

 

11 Oct 2024

 

Image source (image above): vovan / Shutterstock.com

5 questions for the first author

Dr Mark Johan Schuuring, University of Twente (NL)

 

What is the reason for and aim of the publication?

 

We have written this paper because digital solutions for the optimisation of guideline-directed medical therapy (GDMT) are quite new. What is particularly positive is that many different groups and organisations were involved in finding this consensus. The first goal was to classify the different types of digital solutions that can perform this optimisation. Then the different types of digital solutions that are currently available were critically evaluated. The overall goal is to optimise therapy and close the gap between what is prescribed in clinical practice and what the guidelines recommend.

 

What are the most important take-home messages?

 

We classified 5 types of digital solutions – digital consults, digital remote monitoring, multifaceted intervention, implantable devices and CDSS (clinical decision support system):

Fig.: 5 Types of digital solutions to optimize guideline-directed medical therapy (GDMT) prescription rates in patients with heart failure. CDSS (clinical decision support system) © 2024 the European Society of Cardiology. Eur Heart J Digit Health, ztae064, https://doi.org/10.1093/ehjdh/ztae064.

For each type, we have summarised the key features, interpretation of the literature, best practices and knowledge gaps.

 

Furthermore, the following aspects are important:

 

  • We should embrace the different types of digital solutions more fully and there is still a lot to explore and implement in this area.
  • Raising awareness: Clinicians need to be better informed about sub-optimal prescribing of GDMT to improve compliance with guidelines. They should also be informed about digital solutions that can support them.
  • Although artificial intelligence is widely discussed, there is limited data on optimising heart failure and more research is needed.
  • The use of multifaceted interventions is a promising approach, combining multiple digital solutions to achieve better outcomes. This is also underlined by a recent randomised controlled trial of multifaceted digital consults in heart failure care which I published with a research team in Nature Medicine.

 

What are challenges in practical implementation – and possible solutions?

 

Many people have ideas for digital solutions but don't know where to start because the field is too broad and too vague. We have listed best practices in the consensus paper, such as the integration of electronic health records or the use of secure and reliable platforms. These definitions in the consensus statement with steps for implementation and best practices can help people get started.

 

Which issues still need to be tackled, that are not yet addressed by the paper?

 

Larger outcome studies are necessary. At the moment, we mostly have smaller pilot studies that demonstrate the concept. The next step is larger studies, similar to drug trials, in which a large number of patients participate. The same applies to artificial intelligence, where we are generating plenty of results on workflow improvements, but still too few on clinical outcomes.

 

What further developments on the topic are emerging?

 

We are gaining more and more insight into the field of digital health. It is becoming clear that simply monitoring data is not enough – real action needs to be taken based on that data. We need "nudging tools" that put clinicians in an active role for the next step: For example, in the study published in Nature Medicine, clinicians were given a summary of telemonitoring data, heart rate, blood pressure, previous medication, patient wellbeing, a comparison with guidelines and then very specific next steps. This information was available to the clinicians in the electronic health record before each consultation. This works better than alerts or notifications that are clicked away. The focus needs to be on actively engaging clinicians rather than passively watching the data. This kind of smart active approach is key to the future of digital interventions.

Continue to the publication presented:

Clinical consensus statement: "Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure"

Reference: Schuuring MJ, Treskes RW, Castiello T, et al, Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum, European Heart Journal - Digital Health, 2024. https://doi.org/10.1093/ehjdh/ztae064

 

About the person

Dr Mark Johan Schuuring

Dr Mark Schuuring is a Cardiologist at the Medical Spectrum Twente (Netherlands) and Researcher at the Department of Biomedical Signals and Systems. His research focusses on eHealth and artificial intelligence in Cardiology. He published over 80 peer-reviewed articles, including papers in Nature Medicine, European Heart Journal – Digital Health and European Journal of Heart Failure.


Kurzinfo: Die Formate der DGK-Publikationen

Leitlinien sind für Ärztinnen und Ärzte eine wichtige Stütze im klinischen Alltag, um ihre Patientinnen und Patienten nach neuestem Stand der Wissenschaft bestmöglich zu behandeln. Dabei dienen die Leitlinien als verlässliche Handlungsempfehlungen in spezifischen Situationen.

Pocket-Leitlinien sind Leitlinien in kompakter, praxisorientierter Form. Bei Übersetzungen von Pocket-Leitlinien der ESC werden alle Empfehlungsklassen und Evidenzgrade der Langfassung übernommen.

Master Pocket-Leitlinien stellen eine Zusammenfassung der wichtigsten Aspekte der Leitlinienempfehlungen in Form von grafischen Diagnose- und Therapiealgorithmen dar. Als Quelle der Empfehlungen dienen dabei vorwiegend die nach strengen wissenschaftlichen Kriterien erstellten Leitlinien der European Society of Cardiology (ESC) sowie deren deutsche Übersetzung durch die DGK.

CardioCards behandeln im Wesentlichen Themen der Diagnostik und Akuttherapie für den ambulanten Bereich. Hier werden die essenziellen Informationen von Leitlinien komprimiert und übersichtlich zusammengefasst.

Kommentare beinhalten Hinweise, wie sich die neuen von den alten Leitlinien unterscheiden, Hinweise auf wesentliche Neuerungen, die seit dem Erscheinen der ESC-Leitlinien bekannt geworden sind, Diskussion kontroverser Empfehlungen in den ESC-Leitlinien sowie Möglichkeiten und Grenzen der Leitlinienumsetzung im Bereich des deutschen Gesundheitswesens.

Ein Positionspapier behandelt eine Fragestellung von großem allgemeinen Interesse, für die keine aktuelle Leitlinie vorliegt.

Bei einem Konsensuspapier handelt es sich um ein von mehreren Fachgesellschaften getragenes Statement.

Diese Veröffentlichungen enthalten Empfehlungen einer DGK-Arbeitsgruppe zu einer speziellen Frage von großem Interesse.

Stellungnahmen der DGK beziehen sich auf gesundheitspolitische Fragestellungen und erfolgen durch den Vorstand, gemeinsam mit Kommissionen und Projektgruppen. Sofern möglich und sinnvoll, werden auch Fachgesellschaft-übergreifende Stellungnahmen ausgearbeitet.

Ein Manual ist eine praktisch orientierte Expertenempfehlung für wesentliche kardiovaskuläre Prozeduren.

Das könnte Sie auch interessieren

Hot Line 5: Neue Daten zu M-TEER

ESC-Kongress 2024 | RESHAPE-HF2 & MATTERHORN: Beide Studien bestätigten den Nutzen der M-TEER bei symptomatischer Mitralinsuffizienz. Kommentiert von PD Dr. C. Frerker.

Quick Dive: DGK-Kommentar zur infektiösen Endokarditis

Publikationen von Fachgesellschaften prägnant vorgestellt – dieses Mal: DGK-Kommentar zu den ESC-Leitlinien 2023 zur infektiösen Endokarditis. Von PD Dr. S. de Waha und Prof. M. Borger.

Hot Line 5: Neues zu TAVI

ESC-Kongress 2024 | NOTION-3 & RHEIA: PCI im Rahmen der TAVI bei stabiler KHK sowie TAVI-Outcome bei Frauen. Von Dr. M. Gerçek & Prof. T. Rudolph.

Laden, bitte warten.
Diese Seite teilen